Horsham is the primary world site for performing preclinical photosafety studies.   But what are the next steps when a test article is identified with phototoxic liability, and the indication or unmet need for that test article makes a compelling reason to move to the clinic?  This presentation will briefly cover the work we do here, and then cover the clinical evaluation of phototoxicity to either derisk or define the risk of that potential drug to patients.